Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 28
Filter
1.
Rev. bras. oftalmol ; 81: e0070, 2022. graf
Article in English | LILACS | ID: biblio-1407683

ABSTRACT

ABSTRACT Chlorpromazine is a medication widely used in psychiatry for the treatment of psychoses, especially schizophrenia. Since 1964, published articles have been correlating this medication with the appearance of ocular alterations. In this paper, we report the case of a 65-year-old patient with ocular effects due to long-term therapy with chlorpromazine. Biomicroscopy of both eyes presented diffuse granular brown deposits, most prominent at the deep stroma and corneal endothelium level. Also showed anterior subcapsular brown deposits with a stellate pattern in the lens. The total amount exceeds 2.000g (significant for the ocular alterations described) considering the patient's daily dosage of chlorpromazine of 300mg for ten years. After performing complete ophthalmic evaluation and discarding other causes for the ocular deposits, we diagnosed a secondary corneal deposit and cataract due to the use of chlorpromazine. This case reinforces the importance of periodic follow-up with an ophthalmologist for chlorpromazine users to trace ocular changes, heeding the exposure time and its dosage.


RESUMO A clorpromazina é uma medicação muito empregada na psiquiatria para tratamento de psicoses, especialmente em casos de esquizofrenia. Desde 1964 existem artigos publicados que correlacionam o uso dessa medicação com o aparecimento de alterações oculares. Neste trabalho, relatamos o caso de um paciente de 65 anos com efeitos oculares devido à terapia de longo prazo com clorpromazina. A biomicroscopia de ambos os olhos apresentou depósitos granulares difusos e de cor marrom, mais proeminente ao nível do estroma profundo e do endotélio da córnea, além de depósitos castanhos subcapsulares anteriores centrais em um padrão estrelado no cristalino. Considerando a dose diária de clorpromazina de 300mg por 10 anos usada pelo paciente, a quantidade total ultrapassa 2.000g (dose considerada significativa para as alterações oculares descritas). Após avaliação oftalmológica completa e descartado outras causas desses depósitos oculares, foram diagnosticados depósito corneano e catarata secundários ao uso de clorpromazina. O caso apresentado reforça a importância do acompanhamento oftalmolÓgico periÓdico de usuários de clorpromazina para o rastreio de alteraçÕes oculares, atentando-se ao tempo de exposição à droga e à posologia da mesma.


Subject(s)
Humans , Male , Aged , Cataract/chemically induced , Chlorpromazine/adverse effects , Chlorpromazine/toxicity , Cornea/drug effects , Corneal Diseases/chemically induced , Corneal Opacity/chemically induced , Pigmentation Disorders/chemically induced , Antipsychotic Agents/adverse effects , Antipsychotic Agents/toxicity , Antipsychotic Agents/therapeutic use , Bipolar Disorder/drug therapy , Visual Acuity , Chlorpromazine/administration & dosage , Chlorpromazine/therapeutic use , Corneal Diseases/diagnosis , Corneal Opacity/diagnosis , Slit Lamp , Slit Lamp Microscopy
2.
Rev. bras. oftalmol ; 75(2): 132-136, Mar.-Apr. 2016. tab, graf
Article in Portuguese | LILACS | ID: lil-779970

ABSTRACT

RESUMO Objetivo: O objetivo desde estudo foi avaliar a efetividade da triancinolona intra-vítrea e da clorpromazina retrobulbar como alternativas no manejo da dor ocular em olhos cegos. Métodos: Este foi um estudo prospectivo intervencionista não-randomizado de pacientes com olho cego doloroso não responsivo ao tratamento tópico e sem indicação de evisceração atendidos no Serviço de Oftalmologia do Hospital Governador Celso Ramos no ano de 2010. Após exame oftalmológico e ultrassonografia ocular modo B, os pacientes foram divididos em dois grupos. Pacientes do Grupo 1 possuíam glaucoma intratável e receberam injeção retrobulbar de clorpromazina 2,5ml, e pacientes do Grupo 2 possuíam olhos phthisicos com componente inflamatório e receberam injeção intra-vítrea de triancinolona 0,3ml. Foram realizadas avaliações com 1, 3 e 6 meses após o procedimento e a dor quantificada de forma subjetiva em uma escala de 0 a 10 (sem dor e com o máximo de dor, respectivamente). Resultados: Foram incluídos 38 olhos, sendo 15 no Grupo 1 e 21 no Grupo 2. Houve predomínio do sexo masculino e idade média de 54 anos. A causa mais prevalente de olho cego doloroso foi o glaucoma neovascular. Tanto a injeção de clorpromazina retrobulbar quanto a de triancinolona intra-vítrea mostraram-se eficazes no controle da dor ocular em olhos cegos no período do estudo (p<0,001). Ocorreu uma redução de 77,1% no uso de colírios (p<0,01) após a aplicação das medicações. Conclusão: Tanto a injeção de clorpromazina retrobulbar quanto a de triancinolona intra-vítrea mostraram resultados significativos no controle da dor ocular em olhos cegos, além de uma redução no uso de colírios. A clorpromazina é um medicamento de baixo custo, com melhor perfil de efeitos adversos e mostrou resultados discretamente melhores relação à triancinolona. Possíveis viéses identificados no estudo são o de tempo e seleção.


ABSTRACT Objective: The objective of this study was to evaluate the efficacy of intravitreal triamcinolone and retrobulbar chlorpromazine as alternatives in the management of ocular pain in blind eyes. Methods: This was a non-randomized interventional prospective study of patients with painful blind eye unresponsive to topical treatment and without indication of evisceration treated at the Hospital Governador Celso Ramos Ophthalmology Service in 2010. After ocular examination and ocular B mode ultrasound, patients were divided into two groups. Group 1 patients had intractable glaucoma and received retrobulbar injection of chlorpromazine 2.5ml, and Group 2 patients had phthisics eyes with inflammatory component and received intravitreal triamcinolone injection 0.3ml. Evaluations were performed at 1, 3 and 6 months after the procedure and quantified pain subjectively on a scale from 0 to 10 (no pain and maximum pain, respectively). Results: 38 eyes were included, 15 in Group 1 and 21 in Group 2. There was a predominance of males with a mean age of 54 years. The most prevalent cause of painful blind eye was the neovascular glaucoma. Any retrobulbar injection of chlorpromazine as the intravitreal triamcinolone shown to be effective in the control of ocular pain in the eye blind study period (p <0.001). There was a 77.1% reduction in eye drops (p <0.01) after application of medication. Conclusion: Both the retrobulbar injection chlorpromazine as the intravitreal triamcinolone showed significant results in the control of ocular pain in blind eyes, and a reduction in the use of eye drops. Chlorpromazine is a low cost product, with a better adverse effect profile and showed slightly better results compared to triamcinolone. Potential bias identified in the study are the time and selection.


Subject(s)
Humans , Male , Female , Middle Aged , Triamcinolone/administration & dosage , Chlorpromazine/administration & dosage , Blindness/complications , Eye Pain/etiology , Eye Pain/drug therapy , Retinal Vein Occlusion/complications , Retinal Detachment/complications , Triamcinolone/therapeutic use , Chlorpromazine/therapeutic use , Glaucoma, Open-Angle/complications , Glaucoma, Neovascular/complications , Prospective Studies , Diabetic Retinopathy/complications , Intravitreal Injections , Injections , Intraocular Pressure
5.
Pesqui. vet. bras ; 30(2): 108-114, fev. 2010. ilus
Article in Portuguese | LILACS | ID: lil-544452

ABSTRACT

A isquemia renal está presente em diferentes situações como em cirurgias renais, vasculares e no transplante renal. O objetivo deste trabalho foi avaliar a integridade e a função renal de cães submetidos à isquemia e reperfusão com ou sem aplicação de clorpromazina. Para tanto foram utilizados 12 cães distribuídos aleatoriamente em dois grupos de seis indivíduos: grupo A com isquemia e reperfusão sem tratamento por clorpromazina e o grupo B com isquemia e reperfusão tratados previamente com clorpromazina. De cada cão foi coletado sangue e urina antes da isquemia, no inicio da reperfusão, após 120 minutos de reperfusão e semanalmente até 28º dia pós-cirúrgico para verificar possíveis efeitos tardios da isquemia/reperfusão. Avaliações da integridade e função renal foram feitas por exame físico, concentração sérica de ureia e creatinina e determinação da GGT urinária. A avaliação da relação proteína urinária/creatinina urinária (PU/CU) e atividade da GGT urinária são exames mais sensíveis para detectar lesão tubular aguda que o exame de urina de rotina, uma vez que estas variáveis apresentaram alteração mais precocemente. Não houve ação protetora da clorpromazina conforme constatado por meio da urinálise, dosagens séricas de ureia e creatinina, excreção urinária de GGT e PU/CU.


Renal ischemia may occur in different situations such as vascular or renal surgery and also in renal transplantation. This study evaluates renal function in dogs submitted to ischemia and reperfusion after chlorpromazine application. Twelve adult mongrel dogs were distributed into two groups with six animals each. Group A was composed of dogs submitted to renal ischemia and reperfusion without previous administration of chlorpromazine. Group B was composed of dogs with renal ischemia and reperfusion previously treated with chlorpromazine. In order to evaluate the possible ischemia/reperfusion late effects, blood and urine samples were sampled in four different times: Before ischemia, early stages of reperfusion, 120 minutes after reperfusion, and every week until 28th day postsurgery. Renal function was evaluated by clinical examination, serum urea and creatinine levels and urinary GGT activity. PU/CU and GGT urinary activity were more sensitive in detecting acute tubular injury than routine urine examination because these variables showed earlier changes. Based on urinalysis, urea and creatinine serum levels plus urinary excretion of GGT and PU/CU, no evidences of protective action of chlorpromazine were observed.


Subject(s)
Animals , Male , Adult , Dogs , Chlorpromazine/administration & dosage , Renal Insufficiency/surgery , Ischemia/surgery , Reperfusion/adverse effects , Animal Experimentation , Chlorpromazine/therapeutic use , Models, Animal , gamma-Glutamyltransferase/therapeutic use
6.
Arq. neuropsiquiatr ; 67(2a): 195-202, June 2009. tab
Article in English | LILACS | ID: lil-517061

ABSTRACT

OBJECTIVE: The aim of our study was to evaluate the effects of low doses of clozapine in flexible regime in comparison with haloperidol and chlorpromazine in long term. METHOD: The naturalistic study was prospective, active-controlled with 325 adult outpatients of both genders (140 females), with mean year age of 34.8 (range 21-57), suffering from chronic schizophrenia. The first onset of illness was at the mean of 27.9 years (range 17-38), and subjects had the mean year age of 4.1±0.5 previous relapses. The patients were allocated to receive haloperidol (105 subjects, dose range 2-15 mg), chlorpromazine (n=105, 100-400 mg) or clozapine (n=115, 75-600 mg). The scores of psychometric instruments (GWB, PANSS, CGI) were regularly assessed during 5 year period. RESULTS: The sixty-six responders were included in per-protocol analysis: 12, 10 and 16 with positive and 7, 6 and 15 with negative schizophrenic syndrome in haloperidol, chlorpromazine and clozapine group, respectively. The statistically significant differences in all psychometric scores was found, for both schizophrenic syndromes, favoring clozapine. The distribution of eighteen different types of adverse events, which we noted, were significantly different among treatment groups ( ÷2=315.7, df=34, p<0.001). Clozapine was safer and had fewer adverse effects (average of 0.9 adverse events per patient) than haloperidol (2.7) and chlorpromazine (3.2). CONCLUSIONS: Clozapine, in low doses of flexible regime, in long term (five years) showed better effectiveness in chronic schizophrenics with positive and negative symptoms than typical antipsychotics.


OBJETIVO: O propósito deste estudo foi avaliar os efeitos de baixas doses de clozapina em regime flexível comparando com o uso de haloperidol e clorpromazina por período de 5 anos. MÉTODO: Um estudo prospectivo naturalístico, ativo-controlado foi realizado com 325 pacientes com idade média de 34,8 (variância 21-57). Todos com diagnóstico de esquizofrenia. No primeiro surto da doença os pacientes apresentavam idade média de 27,9 anos (variância 17-38) e os surtos subsequentes apareceram em média 4,1±0,5 anos após. Os pacientes foram orientados a receberem haloperidol (105 pacientes com dose entre 2 e 15 mg), clorpromazina (105 pacientes com dose entre 100 e 400 mg) e clozapina (115 pacientes com dose entre 75 e 600 mg). Os instrumentos psicométricos utilizados (GWB, PANSS e CGI) foram regularmente empregados durante os 5 anos do estudo. RESULTADOS: Os 66 pacientes respondedores ao tratamento foram incluídos no protocolo de análise: 12, 10 e 16 apresentavam síndrome esquizofrênica positiva e 7, 6 e 15 síndrome negativa esquizofrênica com haloperidol, clorpromazina e clozapina, respectivamente. Diferenças estatísticas significantes foram observadas em todas as avaliações psicométricas em ambas síndromes esquizofrênicas favorecendo a clozapina. A distribuição de 18 tipos de efeitos colaterais observados foi diferente de modo significativo entre os 3 grupos estudados. A clozapina foi a droga que apresentou menos efeitos colaterais. CONCLUSÃO: A clozapina administrada por longo termo em pequenas doses em regime flexível apresenta melhor eficácia nas síndromes esquizofrênicas quando comparada a outras drogas antipsicóticas.


Subject(s)
Adult , Female , Humans , Male , Antipsychotic Agents/administration & dosage , Chlorpromazine/administration & dosage , Clozapine/administration & dosage , Haloperidol/administration & dosage , Schizophrenia/drug therapy , Antipsychotic Agents/adverse effects , Chlorpromazine/adverse effects , Clozapine/adverse effects , Drug Administration Schedule , Haloperidol/adverse effects , Prospective Studies , Time Factors , Treatment Outcome
7.
Indian J Exp Biol ; 2007 Feb; 45(2): 175-9
Article in English | IMSEAR | ID: sea-60424

ABSTRACT

An important goal of current neuroleptic research is to develop antipsychotic compounds with the low incidence of extrapyramidal side effects. The therapeutic success and less side-effect of atypical anti-psychotics such as clozapine and risperidone has focused the attention on the role of receptor systems other than dopaminergic system in the pathophysiology of neuroleptics-associated extrapyramidal side effects. The present study compares the effect of chronic administration of typical and atypical antipsychotics on neurochemical profile in rat forebrain. The study was planned to study changes in extracellular levels of norepinephrine, dopamine and serotonin in forebrain region of brain and tried to correlate them with hyperkinetic motor activities (vacuous chewing movements (VCM's), tongue protrusions and facial jerking) in rats, hall mark of chronic extrapyramidal side-effect of neuroleptic therapy tardive dyskinesia. Chronic administration of haloperidol (1 mg/kg) and chlorpromazine (5 mg/kg) resulted in significant increase in orofacial hyperkinetic movements where as clozapine and risperidone showed less significant increase in orofacial hyperkinetic movements as compared to control. There were also significant decrease in the extracellular levels of neurotransmitters dopamine, norepinephrine and serotonin in fore-brain as measured by HPLC/ED after chronic administration of haloperidol and chlorpromazine. Chronic administration of atypical neuroleptics clozapine and risperidone resulted in the decrease in extracellular concentration of dopamine and norepinephrine but the effect was less significant as compared to typical drugs. However, treatment with atypical neuroleptics resulted in 3 fold increase in serotonin levels as compared to forebrain of control rats. Typical and atypical neuroleptics showed varying effects on neurotransmitters, especially serotonin which may account for the difference in their profile of side effects (Tardive dyskinesia).


Subject(s)
Animals , Antipsychotic Agents/administration & dosage , Body Weight/drug effects , Chlorpromazine/administration & dosage , Clozapine/administration & dosage , Dopamine/analysis , Dyskinesia, Drug-Induced/pathology , Haloperidol/administration & dosage , Male , Norepinephrine/analysis , Prosencephalon/chemistry , Rats , Rats, Wistar , Risperidone/administration & dosage , Serotonin/analysis
8.
Indian J Exp Biol ; 1999 Dec; 37(12): 1245-7
Article in English | IMSEAR | ID: sea-62750

ABSTRACT

Effect of chlorpromazine with biological metal ions, viz. calcium, magnesium, zink and copper was studied on T. ferrooxidans cell system. Chlorpromazine, calcium and magnesium alone could produce radioprotection. Maximum radioprotection was exhibited by chlorpromazine at lower concentration while copper and zink offered radiosensitization. However, combination of chlorpromazine with all biological metal ions exhibited radiosensitization. Dose modifying factor by chlorpromazine at lower concentration (0.025 mM) was 0.754 while in combination with Ca2+, Mg2+, Cu2+ and Zn2+ was 1.08, 1.25, 1.37 and 1.389 respectively. The possible interaction between chlorpromazine and biological metal ions is discussed at cellular membrane level.


Subject(s)
Cell Membrane/drug effects , Chlorpromazine/administration & dosage , Drug Interactions , Metals/administration & dosage , Radiation-Protective Agents/administration & dosage , Radiation-Sensitizing Agents/administration & dosage , Thiobacillus/drug effects
9.
Arq. neuropsiquiatr ; 57(3B): 813-9, set. 1999. tab, graf
Article in Portuguese | LILACS | ID: lil-247390

ABSTRACT

Cefaléia é dos sintomas mais comuns na prática clínica. Acarreta considerável impacto econômico e sobrecarrega as unidades de emergência. A maioria destas, em nosso país, não dispõe de triptans. O presente estudo analisa o tratamento instituído na Unidade de Emergência do Hospital das Clínicas de Ribeirão Preto. Em 1996, 1254 pacientes foram atendidos com esta queixa e 64 necessitaram de internação. Dos pacientes não internados (NI), 77 por cento apresentavam cefaléias primárias, contra 29,7 por cento dos pacientes internados (I). A percentagem de melhora nos pacientes com migrânea com a dipirona endovenosa foi 83,8 por cento, com o diclofenaco intramuscular 66,7 por cento e com a clorpromazina (endovenosa) 81,8 por cento. As percentagens de pacientes com cefaléia do tipo tensinoal que melhoraram, frente às mesmas drogas foram, respectivamente 77,8 por cento, 80 por cento e 100 por cento. Dos NI 16,3 por cento tiveram melhora sem qualquer tratamento medicamentoso. Concluímos que as drogas utilizadas apresentam perfis semelhantes de eficácia e custo, podendo ser utilizadas em unidades básicas de saúde. O maior inconveniente é a administração parenteral.


Subject(s)
Humans , Male , Female , Child, Preschool , Child , Adolescent , Adult , Middle Aged , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Antiemetics/therapeutic use , Chlorpromazine/therapeutic use , Diclofenac/therapeutic use , Dipyrone/therapeutic use , Emergency Medical Services , Headache/drug therapy , Aged, 80 and over , Anti-Inflammatory Agents, Non-Steroidal/administration & dosage , Antiemetics/administration & dosage , Chlorpromazine/administration & dosage , Diclofenac/administration & dosage , Dipyrone/administration & dosage , Headache/etiology , Migraine Disorders/drug therapy , Retrospective Studies , Tension-Type Headache/drug therapy
10.
Indian J Physiol Pharmacol ; 1997 Apr; 41(2): 123-8
Article in English | IMSEAR | ID: sea-107690

ABSTRACT

Effects of excitatory aminoacids (EAAs) aspartate (ASP) and glutamate (GLU) in a low (50 ng, i.c.) and high dose (20 micrograms, i.c.), were studied on nociception, catalepsy and rectal temperature in albino rats. Both ASP and GLU altered the tail flick reaction time to thermal stimulation in a dose dependent manner, increasing it with low doses and reduced with high doses. Naloxone (10 micrograms, ic) antagonized the anti-nociceptive effect of EAAs while ketamine (10 micrograms, ic)-a NMDA receptor antagonist antagonized the hyperalgesic effect. These EAAs also antagonized catalepsy induced by haloperidol, chlorpromazine, trifluoperazine and morphine. Both ASP and GLU produced a hyperthermic response in all animals, including those in which hypothermia was induced by reserpine. These EAAs produced a comparable central modulatory effects on nociception, catalepsy and core temperature.


Subject(s)
Adrenergic Uptake Inhibitors/toxicity , Analgesia , Analgesics, Opioid/administration & dosage , Animals , Aspartic Acid/administration & dosage , Body Temperature/drug effects , Catalepsy/drug therapy , Chlorpromazine/administration & dosage , Dopamine Antagonists/administration & dosage , Dose-Response Relationship, Drug , Excitatory Amino Acid Antagonists/toxicity , Fever/chemically induced , Glutamic Acid/administration & dosage , Haloperidol/administration & dosage , Hypothermia/chemically induced , Injections, Subcutaneous , Ketamine/pharmacology , Male , Morphine/administration & dosage , Naloxone/administration & dosage , Narcotic Antagonists/administration & dosage , Nociceptors/drug effects , Rats , Reserpine/toxicity , Trifluoperazine/administration & dosage
11.
Med. intensiva ; 13(1): 15-9, 1996. ilus, tab
Article in Spanish | LILACS | ID: lil-195362

ABSTRACT

El síndrome de hiperactividad simpática en el marco del tétanos severo, es un cuadro de gravedad extrema por ya ser una de las principales causas de muerte. Fisiopatológicamente continúa siendo un "misterio", tratáse de explicar todo lo que ocurre debido a la elevada concentración de catecolaminas circulantes. Sin embargo, poco se sabe sobre el comportamiento de la oxigenación de los tejidos durante las crisis disautonómicas, dada las dificultades que existen para su diagnóstico, detección precoz y ausencia de literatura al respecto. Por tal motivo nos propusimos evaluar en forma prospectiva los pacientes con tétanos severo sometidos a monitoreo hemodinámico invasivo y de la perfusión del territorio esplácnico, particularmente durante los episodios de sobreactividad del sistema nervioso autónomo. Así, durante 20 crisis disautonómicas desarrolladas en 12 pacientes consecutivos se evidenció una profunda depresión miocárdica e hipoxia tisular, los que pueden constituir factores de riesgo clave que ayuden a explicar la elevada morbimortalidad cuando el síndrome hace su aparición en el marco del tétanos severo


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Catecholamines/adverse effects , Autonomic Nervous System Diseases/diagnosis , Tetanus/complications , Tetanus Toxin/adverse effects , Chlorpromazine/administration & dosage , Chlorpromazine/therapeutic use , Autonomic Nervous System Diseases/epidemiology , Autonomic Nervous System Diseases/mortality , Hypoxia/complications , Oxygen Consumption , Pancuronium/administration & dosage , Pancuronium/therapeutic use , Prospective Studies , Tetanus/mortality
12.
Arq. bras. med. vet. zootec ; 46(6): 637-45, dez. 1994. ilus, tab
Article in Portuguese | LILACS | ID: lil-239899

ABSTRACT

O objetivo deste trabalho foi produzir anestesia barbitúrica de longa duraçäo, com emprego de tiopental, sem realizaçöes constantes da droga. Foram empregados 70 cäes, sem raça definida, adultos, de ambos os sexos e com pesos entre 8 e 12 kg. A cada animal foi administrado, por via intravenosa, 25 mg/kg de tiopental. Decorridos 10 minutos, foi aplicado, pela mesma via, 1 mg/kg de clorpromazina. Aguardaram-se 10 minutos e aplicou-se diazepam, na dose de 1 mg/kg, também por via intravenosa. Todos os animais foram submetidos à procedimentos cirúrgicos diversos e mensuraram-se as frequências cardíaca e respiratória e a temperatura retal, a intervalos de 10 minutos, durante 160 minutos. Pôde-se observar anestesia cirúrgica por 120 a 250 minutos. Näo se observaram variaçöes significativas nos resultados, à exceçäo de temperatura retal, que decresceu significativamente. Face ao extenso período de recuperaçäo, concluiu-se que a técnica é inadequada para uso na rotina clínica cirúrgica


Subject(s)
Animals , Dogs , Chlorpromazine/administration & dosage , Diazepam/administration & dosage , Hypnotics and Sedatives/administration & dosage , Thiopental/administration & dosage , Anesthesia
13.
Rev. psiquiatr. clín. (São Paulo) ; 20(4): 154-5, dez. 1993. ilus
Article in Portuguese | LILACS | ID: lil-154778

ABSTRACT

E relatado o caso de uma adolescente com anorexia e desnutricao severa, submetida a nutricao parenteral, sem resultados. Realizada avaliacao psiquiatrica, foi feito o diagnostico de Anorexia Nervosa, tendo boa evolucao com o uso de clorpromazina


Subject(s)
Humans , Female , Adolescent , Anorexia Nervosa/therapy , Chlorpromazine/therapeutic use , Anorexia Nervosa/diagnosis , Chlorpromazine/administration & dosage
14.
Article in English | IMSEAR | ID: sea-86027

ABSTRACT

The effect of sodium nitroprusside (SNP), a vasodilator drug, and chlorpromazine (CPZ), a surface active drug, on the efficacy of peritoneal dialysis was studied in 25 patients with acute or acute on chronic renal failure in a double blind fashion. Each drug was added to the dialysate during different sets of cycles. In each patient, six clearance periods of 3 cycles each were studied and peritoneal clearances of creatinine and urea and ultrafiltration rates were measured during each clearance period. SNP increased the peritoneal clearance of creatinine and urea by 28.8 percent each (p < 0.001) while CPZ increased the peritoneal creatinine and urea clearance by 17.7 and 26.0 percent respectively (p < 0.001 each). Both drugs significantly increased the ultrafiltration rates (p < 0.001). SNP was found to be superior to CPZ and had prolonged effect even after cessation of administration.


Subject(s)
Adult , Aged , Chlorpromazine/administration & dosage , Dialysis Solutions , Female , Humans , Acute Kidney Injury/therapy , Kidney Failure, Chronic/therapy , Male , Middle Aged , Nitroprusside/administration & dosage , Peritoneal Dialysis
15.
Neuroeje ; 9(3): 62-8, 1991. ilus
Article in Spanish | LILACS | ID: lil-169587

ABSTRACT

Con el propósito de demostrar la seguridad y eficacia del uso de la clorpromazina vía intravenosa como terapia abortiva en el manejo de la crisis aguda de migraña y en el status migrañoso, y de demostrar que una sola dosis de 10 mgs es tan efectiva y segura como dosis repetidas de 5 mgs, se aplicó el medicamento a 24 pacientes que se presentaron al Servicio de Emergencias del Hospital México.


Subject(s)
Humans , Male , Female , Chlorpromazine/administration & dosage , Chlorpromazine/therapeutic use , Migraine Disorders/drug therapy , Costa Rica
16.
Rev. venez. cir ; 44(2): 61-6, 1991. tab
Article in Spanish | LILACS | ID: lil-121764

ABSTRACT

El aumento del calcio iónico intracelular constituye uno de los fenómenos involucrados en la lesión celular por isquemia y reperfusión. Utilizando un modelo experimental de isquemia hepática segmentaria en ratas se evalúan los efectos de la nimodipina y la clorpromazina, dos drogas que regulan elcalcio intracelular. Como indicadores se utilizan LDH, TGO y TGP, antes de la isquemia y a las 48 horas; el experimento incluye cuatro (4) grupos de ratas: un grupo para cada droga, un grupo control con isquemia sin tratamiento y un grupo de operación simulada. La LDH muestra valores basales elevados que descienden en todos los grupos con isquemia y se mantienen en el grupo de operación simulada. La TGO se eleva en el grupo control y se mantiene estable en los otros grupos. La TGP se eleva en el grupo control y se mantiene estable en los otros grupos. Esto sugiere un efecto citoproctector de las drogas antes mencionadas en las condiciones de este experimento


Subject(s)
Rats , Animals , Nimodipine/administration & dosage , Chlorpromazine/administration & dosage , Ischemia/drug effects , Liver/blood supply
17.
Rev. cuba. oftalmol ; 3(3): 250-5, sept.-dic. 1990.
Article in Spanish | LILACS | ID: lil-112050

ABSTRACT

El trabajo se realizó en 140 pacientes pediatrícos. La corrección del estrabismo es la intervención quirúrgica más frecuente en el niño y como complicación común en este tipo de cirugía se cita el vómito posoperativo. Distintos autores han usado diversos medicamentos para prevenirlo como el dimenhidrinato, drogas antieméticas activas centralmente como la prometazina, el dehidrobenzoperidol y la hydroxyzina, también la lidocaina, la metoclopramida, la dixyrazina, etcétera. Los resultados que muestran son variables en cuanto a la ocurrencia de esta complicación. En nuestro trabajo no se presentó en ningún paciente después de la anestesia general con tiopental, succinilcolina, intubación endotraqueal, 02-N20 y halotano. Se describe el efecto antiemético de la medicación preanestésica usada por nosotros que consistió en la combinación de atropina 0,05 mg, prometazina 2,5 mg y clorpromazina 2,5 mg por cada 25 libras de peso corporal (hasta una dosis de atropina 0,2 mg, prometazina 10 mg y clorpromacina 10 mg (IV)


Subject(s)
Infant , Child, Preschool , Child , Adolescent , Humans , Anesthesia/adverse effects , Atropine/administration & dosage , Chlorpromazine/administration & dosage , Promethazine/administration & dosage , Strabismus/surgery
18.
Braz. j. med. biol. res ; 23(10): 969-73, 1990. tab
Article in English | LILACS | ID: lil-91634

ABSTRACT

Several studies have indicated that chlorpromazine and its metabolites affect ATP hydrolysis by brain and liver plasma membranes in vitro. The present report examines whether chronic treatment (12 days) with high doses of chlorpromazine (10 and 40 mg/kg) could affect ATP and ADP hydrolysis by synaptosomal fractions from the rate caudate nucleus. Both doses of chlorpromazine caused significant and paralled decreases (23 to 31%) in the ATP and ADP hydrolysis. The parallelism between the effects of chlorpromazine on ATP and ADP hydrolys suggests the participation of a single enzyme (ATP diphosphohydrolase) in nucleotide hydrolysis


Subject(s)
Rats , Animals , Male , Adenosine Diphosphate/metabolism , Adenosine Triphosphate/metabolism , Caudate Nucleus/physiology , Chlorpromazine/therapeutic use , Synaptosomes , Synaptosomes/physiology , Analysis of Variance , Body Weight/drug effects , Chlorpromazine/administration & dosage , Hydrolysis , Rats, Wistar
19.
Rev. méd. IMSS ; 27(5): 359-63, sept.-oct. 1989. ilus
Article in Spanish | LILACS | ID: lil-89374

ABSTRACT

Del 1§ de marzo al 15 de diciembre de 1988, 55 pacientes con preeclampsia severa, fueron sometidas a protocolo estandarizado de manejo. De manera aleatoria a 30 de ellas se les administró nifedipina sublingual como antihipertensivo y a 25 se les administró cloropromazina por vía parenteral, ambos medicamentos demonstraron ser eficaces en el manejo de la hipertensión aguda asociada al embarazo: con un descenso promedio de la presión arterial media de 16.4ñ12.7 mmHg. para la nifedipina y de 14ñ11 mmHg. para la cloropromazina. No se observaron efectos adversos materno-fetales con ninguno de los esquemas utilizados


Subject(s)
Pregnancy , Humans , Female , Pre-Eclampsia/drug therapy , Pregnancy Complications, Cardiovascular/drug therapy , Nifedipine/therapeutic use , Chlorpromazine/therapeutic use , Nifedipine/administration & dosage , Chlorpromazine/administration & dosage , Mexico , Random Allocation
20.
Braz. j. med. biol. res ; 22(3): 351-3, 1989. tab
Article in English | LILACS | ID: lil-70690

ABSTRACT

The aim of the present study was to evaluate the in vivo effect of high chlorpromazine (CPZ) doses on hepatocellular function. Thirty male Wistar rats weighing 200 to 250 g were divided into two groups: control (C, N = 17), injected ip with saline, and CPZ (N = 13), injected ip with high chlorpromazine doses (initial dose of 30 mg/Kg body weight followed by daily doses of 10 mg/Kg for 7 days). No significant differences in serum levels of alanine-aminotransferase, alkaline phosphatase and bilirubin or in mitochondrial function (activated and basal respiration and mitochondrial respiration control(activated/basal ratio) were detected between the two groups


Subject(s)
Rats , Animals , Chlorpromazine/administration & dosage , Liver , Mitochondria, Liver , Chlorpromazine/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL